UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity

PloS one, 2020-08, Vol.15 (8), p.e0237030-e0237030

2020

Volltextzugriff (PDF)

Correction: Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity

PloS one, 2021-04, Vol.16 (4), p.e0249807-e0249807

2021

Volltextzugriff (PDF)

NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia

Blood, 2005-12, Vol.106 (12), p.3948-3954

2005

Volltextzugriff (PDF)

Antitumor Activity of Small Interfering RNA/Cationic Liposome Complex in Mouse Models of Cancer

Clinical cancer research, 2004-11, Vol.10 (22), p.7721-7726

2004

Volltextzugriff (PDF)

NS-018, a selective JAK2 inhibitor, preferentially inhibits CFU-GM colony formation by bone marrow mononuclear cells from high-risk myelodysplastic syndrome patients

Leukemia research, 2014-05, Vol.38 (5), p.619-624

2014

Volltextzugriff (PDF)

Characterization of Human Serum Mannan-Binding Protein Promoter

Journal of biochemistry (Tokyo), 1999-12, Vol.126 (6), p.1004-1012

1999

Volltextzugriff (PDF)

Isolation, Cloning, and Characterization of a Novel Phosphomannan-binding Lectin from Porcine Serum

The Journal of biological chemistry, 2007-04, Vol.282 (17), p.12963-12975

2007

Volltextzugriff (PDF)

NS-018 reduces myeloma cell proliferation and suppresses osteolysis through inhibition of the JAK2 and Src signaling pathways

Blood cancer journal (New York), 2018-06, Vol.8 (7), p.62-5, Article 62

2018

Volltextzugriff (PDF)

Antiproliferative and Antitumor Effects of Azacitidine Against the Human Myelodysplastic Syndrome Cell Line SKM-1

Anticancer research, 2012-03, Vol.32 (3), p.795-798

2012

Volltextzugriff (PDF)

The JAK2-Selective Inhibitor NS-018 Preferentially Suppresses CFU-GM Colony Formation By Bone-Marrow Cells From High-Risk Myelodysplastic Syndrome Patients

Blood, 2013-11, Vol.122 (21), p.1286-1286

2013

Volltextzugriff (PDF)

NS-018, a Selective JAK2V617F Inhibitor, Improves JAK2V617F-Induced Murine Myelofibrosis Without Decreasing The Erythrocyte Or Platelet Count

Blood, 2013-11, Vol.122 (21), p.3847-3847

2013

Volltextzugriff (PDF)

Dual Inhibition of the STAT3 and Src Pathways by NS-018, a JAK2 and Src-Family Kinase Inhibitor, Reduces Myeloma Cell Proliferation and Adhesion and Suppresses Osteoclast Formation

Blood, 2011-11, Vol.118 (21), p.2900-2900

2011

Volltextzugriff (PDF)

Design and synthesis of 3-substituted benzamide derivatives as Bcr-Abl kinase inhibitors

Bioorganic & medicinal chemistry letters, 2006-03, Vol.16 (5), p.1421-1425

2006

Volltextzugriff (PDF)

In vivo antiproliferative effect of NS-187, a dual Bcr-Abl/Lyn tyrosine kinase inhibitor, on leukemic cells harbouring Abl kinase domain mutations

Leukemia research, 2006-11, Vol.30 (11), p.1443-1446

2006

Volltextzugriff (PDF)

Preferential Inhibition of An Activated Form of Janus Kinase 2 (JAK2) by a Novel JAK2 Inhibitor, NS-018

Blood, 2010-11, Vol.116 (21), p.4107-4107

2010

Volltextzugriff (PDF)

Structural factors contributing to the Abl/Lyn dual inhibitory activity of 3-substituted benzamide derivatives

Bioorganic & medicinal chemistry letters, 2007-05, Vol.17 (10), p.2712-2717

2007

Volltextzugriff (PDF)

NS-018, a Potent Novel JAK2 Inhibitor, Effectively Treats Murine MPN Induced by the Janus Kinase 2 (JAK2) V617F Mutant

Blood, 2010-11, Vol.116 (21), p.4106-4106

2010

Volltextzugriff (PDF)

Functional characterization of the bovine conglutinin promoter: presence of a novel element for transcriptional regulation of a C-type mammalian lectin containing a collagen-like domain

Journal of biochemistry (Tokyo), 1998-12, Vol.124 (6), p.1188-1197

1998

Volltextzugriff (PDF)

Simultaneous Targeting of Lyn and Bcr-Abl Kinases by NS-187 Cures Mice Bearing Imatinib-Resistant Leukemic Cells

Blood, 2005-11, Vol.106 (11), p.1518-1518

2005

Volltextzugriff (PDF)

Structural factors contributing to the Al/Lyn dual inhibitory activity of 3-substituted benzamide derivatives

Bioorganic & medicinal chemistry letters, 2007, Vol.17 (10), p.2712-2717

2007

Volltextzugriff (PDF)

A Dual Bcr-Abl/Lyn Tyrosine Kinase Inhibitor, NS-187, Is a Novel Agent for Imatinib-Resistant Leukemia

Blood, 2005-11, Vol.106 (11), p.1522-1522

2005

Volltextzugriff (PDF)

Anti-Tumor Activity of a Novel Bcr-Abl/Lyn Dual Inhibitor, NS-187, in Murine CNS Ph+ Leukemia Models

Blood, 2005-11, Vol.106 (11), p.493-493

2005

Volltextzugriff (PDF)

Metabolic Properties of Normal and Mutant Mannan-Binding Proteins in Mouse Plasma

Biochemical and biophysical research communications, 1999-03, Vol.256 (1), p.231-234

1999

Volltextzugriff (PDF)

Dust mite-dominant sensitization pattern as a causal factor for adult-onset asthma

Allergology International, 2021-07, Vol.70 (3), p.368-369

2021

Volltextzugriff (PDF)

ORMDL3/GSDMB genotype as a risk factor for early-onset adult asthma is linked to total serum IgE levels but not to allergic sensitization

Allergology international, 2021-01, Vol.70 (1), p.55-60

2021

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(77)
Berichte
(1)

Sprache

Englisch
(69)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity

Correction: Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity

NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia

Antitumor Activity of Small Interfering RNA/Cationic Liposome Complex in Mouse Models of Cancer

NS-018, a selective JAK2 inhibitor, preferentially inhibits CFU-GM colony formation by bone marrow mononuclear cells from high-risk myelodysplastic syndrome patients

Characterization of Human Serum Mannan-Binding Protein Promoter

Isolation, Cloning, and Characterization of a Novel Phosphomannan-binding Lectin from Porcine Serum

NS-018 reduces myeloma cell proliferation and suppresses osteolysis through inhibition of the JAK2 and Src signaling pathways

Antiproliferative and Antitumor Effects of Azacitidine Against the Human Myelodysplastic Syndrome Cell Line SKM-1

The JAK2-Selective Inhibitor NS-018 Preferentially Suppresses CFU-GM Colony Formation By Bone-Marrow Cells From High-Risk Myelodysplastic Syndrome Patients

NS-018, a Selective JAK2V617F Inhibitor, Improves JAK2V617F-Induced Murine Myelofibrosis Without Decreasing The Erythrocyte Or Platelet Count

Dual Inhibition of the STAT3 and Src Pathways by NS-018, a JAK2 and Src-Family Kinase Inhibitor, Reduces Myeloma Cell Proliferation and Adhesion and Suppresses Osteoclast Formation

Design and synthesis of 3-substituted benzamide derivatives as Bcr-Abl kinase inhibitors

In vivo antiproliferative effect of NS-187, a dual Bcr-Abl/Lyn tyrosine kinase inhibitor, on leukemic cells harbouring Abl kinase domain mutations

Preferential Inhibition of An Activated Form of Janus Kinase 2 (JAK2) by a Novel JAK2 Inhibitor, NS-018

Structural factors contributing to the Abl/Lyn dual inhibitory activity of 3-substituted benzamide derivatives

NS-018, a Potent Novel JAK2 Inhibitor, Effectively Treats Murine MPN Induced by the Janus Kinase 2 (JAK2) V617F Mutant

Functional characterization of the bovine conglutinin promoter: presence of a novel element for transcriptional regulation of a C-type mammalian lectin containing a collagen-like domain

Simultaneous Targeting of Lyn and Bcr-Abl Kinases by NS-187 Cures Mice Bearing Imatinib-Resistant Leukemic Cells

Structural factors contributing to the Al/Lyn dual inhibitory activity of 3-substituted benzamide derivatives

A Dual Bcr-Abl/Lyn Tyrosine Kinase Inhibitor, NS-187, Is a Novel Agent for Imatinib-Resistant Leukemia

Anti-Tumor Activity of a Novel Bcr-Abl/Lyn Dual Inhibitor, NS-187, in Murine CNS Ph+ Leukemia Models

Metabolic Properties of Normal and Mutant Mannan-Binding Proteins in Mouse Plasma

Dust mite-dominant sensitization pattern as a causal factor for adult-onset asthma

ORMDL3/GSDMB genotype as a risk factor for early-onset adult asthma is linked to total serum IgE levels but not to allergic sensitization

Suchergebnisse filtern